Innovus Pharmaceuticals (OTCMKTS:INNVD) Trading 143.9% Higher – Should You Buy?

Innovus Pharmaceuticals Inc (OTCMKTS:INNVD) rose 143.9% during trading on Monday . The stock traded as high as $3.49 and last traded at $3.00. Approximately 4,300 shares traded hands during trading, a decline of 55% from the average daily volume of 9,592 shares. The stock had previously closed at $1.23.

Innovus Pharmaceuticals Stock Up 143.9 %

The stock’s 50-day moving average is $3.00. The company has a market capitalization of $7.07 million, a PE ratio of -0.72 and a beta of 2.89.

Innovus Pharmaceuticals Company Profile

Innovus Pharmaceuticals, Inc, a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality.